Literature DB >> 9060918

Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma.

Y Adachi1, K Mimori, M Mori, Y Maehara, K Sugimachi.   

Abstract

BACKGROUND: Several studies show various rates of morbidity and mortality after radical operation for gastric carcinoma. Whether or not extended lymph node dissection should be done is still controversial. STUDY
DESIGN: The medical records of 214 patients with node-positive gastric carcinoma who underwent radical gastrectomy and extended lymph node dissection (D2, D3) from 1975 to 1990 were analyzed with reference to the type and cause of postoperative complications.
RESULTS: The overall morbidity rate was 36 percent and was significantly different between patients with distal gastrectomy (19 percent) and total gastrectomy (53 percent) (p < .01). Morbidity after distal gastrectomy correlated with blood loss (593 g compared with 438 g; p < .05) and transfusion (43 percent compared with 21 percent; p < .05), whereas morbidity after total gastrectomy was closely linked to splenectomy (64 percent compared with 40 percent; p < .05) and duration of the operation (227 minutes compared with 204 minutes; p < .05). The morbidity rate was not different, however, between D2 dissection (33 percent) and D3 dissection (40 percent) groups.
CONCLUSIONS: Radical gastrectomy and extended lymph node dissection can be performed with an acceptable morbidity, but total gastrectomy with splenectomy was associated with high morbidity in patients with node-positive gastric carcinoma.

Entities:  

Mesh:

Year:  1997        PMID: 9060918

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  8 in total

1.  Gastric cancer invading the pancreas.

Authors:  Yosuke Adachi
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

2.  Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer.

Authors:  A Gil-Rendo; J L Hernández-Lizoain; F Martínez-Regueira; A Sierra Martínez; F Rotellar Sastre; M Cervera Delgado; V Valentí Azcarate; C Pastor Idoate; J Alvarez-Cienfuegos
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

Review 3.  Gastric cancer surgery: historical background and perspective in Western countries versus Japan.

Authors:  Chun-Dong Zhang; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Ann Transl Med       Date:  2019-09

4.  Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer.

Authors:  Hong Man Yoon; Young-Woo Kim; Byung Ho Nam; Daniel Reim; Bang Wool Eom; Ji Yeon Park; Keun Won Ryu
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

5.  Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial.

Authors:  Young-Woo Kim; Jae-Moon Bae; Young-Kyu Park; Han-Kwang Yang; Wansik Yu; Jeong Hwan Yook; Sung Hoon Noh; Mira Han; Keun Won Ryu; Tae Sung Sohn; Hyuk-Joon Lee; Oh Kyoung Kwon; Seung Yeob Ryu; Jun-Ho Lee; Sung Kim; Hong Man Yoon; Bang Wool Eom; Min-Gew Choi; Beom Su Kim; Oh Jeong; Yun-Suhk Suh; Moon-Won Yoo; In Seob Lee; Mi Ran Jung; Ji Yeong An; Hyoung-Il Kim; Youngsook Kim; Hannah Yang; Byung-Ho Nam
Journal:  JAMA       Date:  2017-05-23       Impact factor: 56.272

6.  Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer.

Authors:  Zi-Yu Li; Fei Shan; Lian-Hai Zhang; Zhao-De Bu; Ai-Wen Wu; Xiao-Jiang Wu; Xiang-Long Zong; Qi Wu; Hui Ren; Jia-Fu Ji
Journal:  World J Surg Oncol       Date:  2011-09-26       Impact factor: 2.754

7.  Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer.

Authors:  Stuart G Marcus; Daniel Cohen; Ke Lin; Kwok Wong; Scott Thompson; Adina Rothberger; Milan Potmesil; Spiros Hiotis; Elliot Newman
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

8.  FAIRY: a randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) to placebo in patients with acute isovolemic anemia after gastrectomy - study protocol for a randomized controlled trial.

Authors:  Daniel Reim; Young-Woo Kim; Byung Ho Nam; Mi-Jung Kim; Jeong Hwan Yook; Young Kyu Park; Sung Hoon Roh; Wan Sik Yu; Jae Moon Bae
Journal:  Trials       Date:  2014-04-05       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.